http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-4950555-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 1998-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7947450e2693eb9916dcfca9a2feb51e
publicationDate 2000-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-4950555-A1
titleOfInvention PHARMACEUTICAL COMPOSITIONS CONTAINING ELEPTRIPTAN HEMISULFATE
abstract An aqueous pharmaceutical composition comprising 5 to 200mg / ml eletriptan hemisulfate and 0.5 to 2.0% w / v caffeine.1 A composition according to claim 1, comprising 120mg / ml eletriptan hemisulfate, 1.5 % w / v caffeine, 0.3% w / v citric acid, and 5% w / v ethanol by buffered composition at pH 7.5 to 8.5, preferably approximately pH 8.0.
priorityDate 1997-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445

Total number of triples: 24.